Medicine and Dentistry
Kidney Tumour
100%
Prostate Cancer
97%
Biopsy Technique
84%
Clear Cell Renal Cell Carcinoma
71%
Partial Nephrectomy
71%
Neoplasm
67%
Magnetic Resonance Imaging
56%
Prostatectomy
55%
Systematic Review
54%
Radical Nephrectomy
44%
Diseases
39%
Malignant Neoplasm
35%
Prostate Biopsy
29%
Health Care Cost
28%
Cancer Specific Survival
27%
Urologic Surgery
26%
Overall Survival
26%
Meta-Analysis
25%
Kidney Cancer
24%
Retroperitoneal Lymph Node Dissection
22%
Cystectomy
22%
Multiparametric Magnetic Resonance Imaging
20%
Seminoma
20%
Prostate Specific Antigen
20%
Urologist
19%
Logistic Regression Analysis
19%
Germinoma
17%
Odds Ratio
17%
Enucleation
17%
Cancer Diagnosis
17%
Cost-Effectiveness Analysis
16%
Robot-Assisted Prostatectomy
16%
Comorbidity
15%
Hazard Ratio
15%
Nephrectomy
14%
Cancer
14%
Surgeon
14%
Clinical Stage
14%
Recurrent Disease
14%
Transitional Cell Carcinoma
14%
Quality of Life
13%
Neoadjuvant Chemotherapy
13%
Bleeding
12%
Urinary System
12%
Bladder
12%
Proportional Hazards Model
11%
Surveillance, Epidemiology, and End Results
11%
Radiation Therapy
11%
Pediatrics
11%
Adjuvant Therapy
10%
Keyphrases
Active Surveillance
79%
Radical Prostatectomy
65%
Small Renal Mass
56%
Renal Cell Carcinoma
55%
Partial Nephrectomy
52%
Prostate Cancer
49%
Radical Nephrectomy
39%
Multiparametric MRI (mpMRI)
39%
Magnetic Resonance Imaging
30%
Cancer-specific Survival
27%
Meta-analysis
26%
Urological Surgery
25%
Postoperative Outcomes
23%
Systematic Meta-analysis
23%
Localized Kidney Cancer
23%
Overall Survival
23%
Clinically Significant Prostate Cancer
20%
Confidence Interval
20%
Tumor
19%
Renal Mass
19%
Kidney Cancer
18%
Low Risk
18%
Prostate Cancer Screening
18%
Urologists
17%
Odds Ratio
17%
Tumor Enucleation
16%
Delayed Intervention
16%
Hazard Ratio
16%
Grade Group
15%
Metastatic Renal Cell Carcinoma (mRCC)
15%
Robotic-assisted
14%
Opioid Prescribing
14%
Neoadjuvant Chemotherapy
13%
Radical Cystectomy
13%
Localized Renal Cell Carcinoma
13%
Patient Selection
13%
Comorbidity
13%
Muscle-invasive Bladder Cancer
13%
Prospective Cohort Study
13%
Prostate Biopsy
13%
Risk Factors
13%
Length of Stay
13%
Robotics
13%
Oncological Outcomes
13%
Data Systems
13%
High Risk
12%
Robot-assisted Radical Prostatectomy
12%
Chemotherapy
12%
Thermal Ablation
12%
United States
12%